Executive Director, Investor Relations and Corporate Communications
Immunome, Inc.
August 07, 2026
Remote friendly (Bothell, WA)
United States
$280,000 - $320,000 USD yearly
Corporate Functions
Responsibilities
- Execute the investor relations program with the CEO and CFO to ensure clear, consistent communication with the capital markets.
- Own day-to-day IR execution, including investor/analyst meeting coordination, targeting support, CRM management, feedback capture, and follow-up.
- Draft core IR materials: investor presentations, fact sheets, FAQs, earnings scripts, Q&A documents, and conference talk tracks.
- Serve as primary point of contact for sell-side analysts; manage logistics/clarifications and correct misinterpretations.
- Coordinate investor conferences, non-deal roadshows, and other capital markets engagements.
- Track, synthesize, and report investor sentiment and market feedback to senior management and the Board.
- Lead corporate communications: draft press releases, corporate updates, pipeline/clinical announcements, and reactive statements.
- Translate complex scientific, clinical, and regulatory information into clear, accurate, investable external messaging.
- Partner with Legal/senior management on Reg FD compliance, disclosure discipline, and risk framing.
- Manage PR and IR agencies; maintain high standards for accuracy, clarity, and quality.
- Support media engagement and spokesperson preparation; handle inbound media inquiries as needed.
- Ensure consistency across external-facing materials and channels.
Qualifications
- 10+ years’ experience in investor relations, corporate communications, or closely related role in biotech/biopharma/life sciences (or equivalent).
- Public company experience, including direct involvement in earnings preparation and material disclosures.
- Proven ability to independently draft high-quality press releases, investor materials, and executive communications.
- Strong scientific literacy for understanding/communicating clinical data and development strategy.
- Strong financial literacy and comfort engaging with analysts/investors/capital markets.
- Experience working with senior executives; trusted execution partner.
- Experience managing external agencies (IR/PR/communications).
- Bachelor’s degree required; advanced degree a plus.
Skills
- Exceptional written/verbal communication; disciplined external messaging.
- Deep understanding of biotech sector dynamics and public equity markets.
- Sound judgment on disclosure, tone, timing, and risk in fast-moving situations.
- Strong analytical, strategic, and presentation skills.
- Ability to operate in a fast-paced environment with precision, professionalism, and confidentiality.
Pay Range (Washington State)
- $280,000 - $320,000 USD
- Execute the investor relations program with the CEO and CFO to ensure clear, consistent communication with the capital markets.
- Own day-to-day IR execution, including investor/analyst meeting coordination, targeting support, CRM management, feedback capture, and follow-up.
- Draft core IR materials: investor presentations, fact sheets, FAQs, earnings scripts, Q&A documents, and conference talk tracks.
- Serve as primary point of contact for sell-side analysts; manage logistics/clarifications and correct misinterpretations.
- Coordinate investor conferences, non-deal roadshows, and other capital markets engagements.
- Track, synthesize, and report investor sentiment and market feedback to senior management and the Board.
- Lead corporate communications: draft press releases, corporate updates, pipeline/clinical announcements, and reactive statements.
- Translate complex scientific, clinical, and regulatory information into clear, accurate, investable external messaging.
- Partner with Legal/senior management on Reg FD compliance, disclosure discipline, and risk framing.
- Manage PR and IR agencies; maintain high standards for accuracy, clarity, and quality.
- Support media engagement and spokesperson preparation; handle inbound media inquiries as needed.
- Ensure consistency across external-facing materials and channels.
Qualifications
- 10+ years’ experience in investor relations, corporate communications, or closely related role in biotech/biopharma/life sciences (or equivalent).
- Public company experience, including direct involvement in earnings preparation and material disclosures.
- Proven ability to independently draft high-quality press releases, investor materials, and executive communications.
- Strong scientific literacy for understanding/communicating clinical data and development strategy.
- Strong financial literacy and comfort engaging with analysts/investors/capital markets.
- Experience working with senior executives; trusted execution partner.
- Experience managing external agencies (IR/PR/communications).
- Bachelor’s degree required; advanced degree a plus.
Skills
- Exceptional written/verbal communication; disciplined external messaging.
- Deep understanding of biotech sector dynamics and public equity markets.
- Sound judgment on disclosure, tone, timing, and risk in fast-moving situations.
- Strong analytical, strategic, and presentation skills.
- Ability to operate in a fast-paced environment with precision, professionalism, and confidentiality.
Pay Range (Washington State)
- $280,000 - $320,000 USD